Rigel 3Q loss narrows on lower costs

SOUTH SAN FRANCISCO, Calif. - Rigel Pharmaceuticals Inc. said Tuesday its third-quarter loss narrowed as the development-stage biotechnology company completed two midstage studies in its rheumatoid arthritis program. [read full story]                    

powered by
Add Comment
There are also 6 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies